InvestSMART

Ramsay Health Care Limited (ASX: RHC) - Announcements

Current share price for RHC : $44.255 0.745 (1.66%)+

ASX company news and announcements for Ramsay Health Care Limited (RHC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ramsay Health Care Limited (RHC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ramsay Health Care Limited (RHC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ramsay Health Care Limited (RHC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10,215 Becoming a substantial holder 30 May 2022 8:21AM $78.410 $44.255 fallen by 43.56%
$10,215 Ceasing to be a substantial holder 27 May 2022 8:22AM $77.370 $44.255 fallen by 42.80%
$10,215 French Government Issues New Funding Guarantee Scheme 16 May 2022 10:15AM $76.910 $44.255 fallen by 42.46%
$10,215 Notification regarding unquoted securities - RHC 5 May 2022 2:09PM $78.485 $44.255 fallen by 43.61%
$10,215 Notice of Termination of Bupa Contract 4 May 2022 4:37PM $79.010 $44.255 fallen by 43.99%
$10,215 Notification regarding unquoted securities - RHC 29 Apr 2022 4:57PM $81.110 $44.255 fallen by 45.44%
$10,215 Change of Director's Interest Notice - K Penrose 29 Apr 2022 1:06PM $81.190 $44.255 fallen by 45.49%
$10,215 Third Quarter FY22 Trading Update 29 Apr 2022 8:05AM $81.550 $44.255 fallen by 45.73%
$10,215 Dividend/Distribution - RHCPA 20 Apr 2022 1:57PM $80.860 $44.255 fallen by 45.27%
$10,215 Response to Media Receipt of Non-Binding Indicative Proposal 20 Apr 2022 8:21AM $64.390 $44.255 fallen by 31.27%
$10,215 Notification regarding unquoted securities - RHC 6 Apr 2022 2:17PM $64.380 $44.255 fallen by 31.26%
$10,215 Initial Director's Interest Notice 6 Apr 2022 1:53PM $64.290 $44.255 fallen by 31.16%
$10,215 Becoming a substantial holder 31 Mar 2022 9:46AM $64.740 $44.255 fallen by 31.64%
$10,215 Receipt of non-binding indicative proposal Ramsay Sime Darby 22 Mar 2022 10:37AM $63.280 $44.255 fallen by 30.06%
$10,215 Update - Dividend/Distribution - RHCPA 24 Feb 2022 8:21AM $64.560 $44.255 fallen by 31.45%
$10,215 Dividend/Distribution - RHC 24 Feb 2022 8:17AM $64.560 $44.255 fallen by 31.45%
$10,215 2022 Calendar of Key Dates 24 Feb 2022 8:12AM $64.560 $44.255 fallen by 31.45%
$10,215 2022 Half year Results Presentation 24 Feb 2022 8:12AM $64.560 $44.255 fallen by 31.45%
$10,215 2022 Half Year Results Announcement 24 Feb 2022 8:11AM $64.560 $44.255 fallen by 31.45%
$10,215 2022 Half Year Financial Report 24 Feb 2022 8:10AM $64.560 $44.255 fallen by 31.45%
$10,215 Update on Elective Surgery Restrictions in NSW 1 Feb 2022 9:26AM $62.790 $44.255 fallen by 29.52%
$10,215 COMPLETION OF ACQUISITION OF ELYSIUM HEALTHCARE 1 Feb 2022 8:32AM $62.790 $44.255 fallen by 29.52%
$10,215 Ramsay Reaches Agreement with NHS England 10 Jan 2022 6:23PM $67.250 $44.255 fallen by 34.19%
$10,215 Update on Elective Surgery Restrictions in Australia 7 Jan 2022 2:41PM $68.420 $44.255 fallen by 35.32%
$10,215 Notification of cessation of securities - RHC 21 Dec 2021 4:11PM $70.310 $44.255 fallen by 37.06%

251 - 275 of 750 results

Page 11 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.